Olopatadine (0.1% w/v) Eye/Ear Drop in PCD pharma franchise in Hyderabad

Olopatadine (0.1% w/v) Eye/Ear Drop in pharmaceutical manufacturing company in Mumbai

Olopatadine (0.1% w/v) Eye/Ear Drop in allergy care pharma franchise in Pune

Olopatadine (0.1% w/v) Eye/Ear Drop in pharma suppliers in Delhi

Olopatadine (0.1% w/v) Eye/Ear Drop in pharma export companies in Kolkata
Olopatadine (0.1% w/v) Eye/Ear Drop in pharma franchise opportunities in Bengaluru

Home/Products /olopatadine-0-point-1-w-v-eye-ear-drop

Oloplit Eye Drops

Composition : Olopatadine (0.1% w/v) eye drop

Dosage Form : Eye Ear Drop

Packaging Type : Dropper

Packaging : 5ml

Price : ₹214/-

Oloplit is an antihistamine ophthalmic solution formulated to provide effective relief from allergic conjunctivitis and ocular irritation. It contains Olopatadine (0.1% w/v), a potent H1 receptor antagonist, which works by inhibiting the release of histamines responsible for allergic symptoms such as itching, redness, and watery eyes.

Oloplit is specifically designed to combat seasonal and perennial allergic conjunctivitis, which may occur due to pollen, dust, pet dander, and environmental pollutants. By stabilizing mast cells, it prevents the onset of allergic reactions, offering long-lasting protection from discomfort. The formulation is non-sedative, making it safe for daily use without drowsiness.

The solution is fast-acting, with noticeable relief occurring within minutes of application, and its long-duration efficacy helps maintain comfort throughout the day. Oloshell is gentle on the eyes, preservative-free, and suitable for individuals wearing contact lenses.

Read More

About the Product

Oloplit is an antihistamine ophthalmic solution formulated to provide effective relief from allergic conjunctivitis and ocular irritation. It contains Olopatadine (0.1% w/v), a potent H1 receptor antagonist, which works by inhibiting the release of histamines responsible for allergic symptoms such as itching, redness, and watery eyes.

Oloplit is specifically designed to combat seasonal and perennial allergic conjunctivitis, which may occur due to pollen, dust, pet dander, and environmental pollutants. By stabilizing mast cells, it prevents the onset of allergic reactions, offering long-lasting protection from discomfort. The formulation is non-sedative, making it safe for daily use without drowsiness.

The solution is fast-acting, with noticeable relief occurring within minutes of application, and its long-duration efficacy helps maintain comfort throughout the day. Oloshell is gentle on the eyes, preservative-free, and suitable for individuals wearing contact lenses.

Possible mild side effects include temporary eye irritation, mild stinging, dryness, or blurred vision. If symptoms persist or worsen, consult an eye specialist.

Oloshell is indicated for the treatment of allergic conjunctivitis, reducing symptoms such as eye redness, itching, tearing, and irritation caused by allergens.

For ophthalmic use only. Avoid touching the dropper tip to prevent contamination. Do not use if the solution appears cloudy or if the seal is broken. If irritation persists, discontinue use and seek medical advice.

Store at room temperature (below 30°C), away from direct sunlight and moisture. Keep the bottle tightly closed when not in use.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation